Literature DB >> 28899000

RHOA-ROCK signalling is necessary for lateralization and differentiation of the developing sinoatrial node.

Rebecca Vicente-Steijn1,2,3, Tim P Kelder1, Leon G Tertoolen1, Lambertus J Wisse1, Daniël A Pijnappels2, Robert E Poelmann4, Martin J Schalij2, Marco C deRuiter1, Adriana C Gittenberger-de Groot1,2, Monique R M Jongbloed1,2.   

Abstract

AIMS: RHOA-ROCK signalling regulates cell migration, proliferation, differentiation, and transcription. RHOA is expressed in the developing cardiac conduction system in chicken and mice. In early development, the entire sinus venosus myocardium, including both the transient left-sided and the definitive sinoatrial node (SAN), has pacemaker potential. Later, pacemaker potential is restricted to the right-sided SAN. Disruption of RHOA expression in adult mice causes arrhythmias including bradycardia and atrial fibrillation, the mechanism of which is unknown but presumed to affect the SAN. The aim of this study is to assess the role of RHOA-ROCK signalling in SAN development in the chicken heart. METHODS AND
RESULTS: ROCK signalling was inhibited chemically in embryonic chicken hearts using Y-27632. This prolonged the immature state of the sinus venosus myocardium, evidenced by up-regulation of the transcription factor ISL1, wide distribution of pacemaker potential, and significantly reduced heart rate. Furthermore ROCK inhibition caused aberrant expression of typical SAN genes: ROCK1, ROCK2, SHOX2, TBX3, TBX5, ISL1, HCN4, CX40, CAV3.1, and NKX2.5 and left-right asymmetry genes: PITX2C and NODAL. Anatomical abnormalities in pulmonary vein development were also observed. Patch clamp electrophysiology confirmed the immature phenotype of the SAN cells and a residual left-sided sinus venosus myocardium pacemaker-like potential.
CONCLUSIONS: RHOA-ROCK signalling is involved in establishing the right-sided SAN as the definitive pacemaker of the heart and restricts typical pacemaker gene expression to the right side of the sinus venosus myocardium. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Arrhythmia; Bradycardia; Cardiac conduction system; Heart development; Sinus node dysfunction

Mesh:

Substances:

Year:  2017        PMID: 28899000     DOI: 10.1093/cvr/cvx104

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  The Bardet-Biedl syndrome protein complex regulates cell migration and tissue repair through a Cullin-3/RhoA pathway.

Authors:  Deng-Fu Guo; Kamal Rahmouni
Journal:  Am J Physiol Cell Physiol       Date:  2019-06-19       Impact factor: 4.249

Review 2.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

Review 3.  Development and evolution of the metazoan heart.

Authors:  Robert E Poelmann; Adriana C Gittenberger-de Groot
Journal:  Dev Dyn       Date:  2019-05-20       Impact factor: 3.780

Review 4.  Signalling pathways implicated in the pathogenesis of rheumatic heart disease (Review).

Authors:  Shenglin Xian; Zhiyu Zeng
Journal:  Exp Ther Med       Date:  2020-11-25       Impact factor: 2.447

5.  The Joint Analysis of Multi-Omics Data Revealed the Methylation-Expression Regulations in Atrial Fibrillation.

Authors:  Ban Liu; Xin Shi; Keke Ding; Mengwei Lv; Yongjun Qian; Shijie Zhu; Changfa Guo; Yangyang Zhang
Journal:  Front Bioeng Biotechnol       Date:  2020-03-12

Review 6.  Rho Kinases in Embryonic Development and Stem Cell Research.

Authors:  Jianjian Shi; Lei Wei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-01-19       Impact factor: 4.291

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.